BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen BL, Zhang GY, Wang SP, Li Q, Xu MH, Shen YM, Yan L, Gu H, Li J, Huang YL. The combined treatment of praziquantel with osteopontin immunoneutralization reduces liver damage in Schistosoma japonicum-infected mice. Parasitology. 2012;139:522-529. [PMID: 22309838 DOI: 10.1017/s0031182011002241] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kong D, Zhou C, Guo H, Wang W, Qiu J, Liu X, Liu J, Wang L, Wang Y. Praziquantel Targets M1 Macrophages and Ameliorates Splenomegaly in Chronic Schistosomiasis. Antimicrob Agents Chemother 2018;62:e00005-17. [PMID: 29061758 DOI: 10.1128/AAC.00005-17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li-zhi W, Xin-Sheng Z, Jiang-shan D, Yi W, Bao-an Y. Transdermal praziquantel administration attenuates hepatic granulomatosis in mice infected with Schistosoma japonicum. Parasitol Res 2015;114:1417-24. [PMID: 25630695 DOI: 10.1007/s00436-015-4324-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 El Ridi RA, Tallima HA. Novel therapeutic and prevention approaches for schistosomiasis: review. J Adv Res 2013;4:467-78. [PMID: 25685454 DOI: 10.1016/j.jare.2012.05.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
4 Tang J, Zhu X, Zhao J, Fung M, Li Y, Gao Z, Yan S, Li X, Ji X, Su F, Li Z. Tissue Transglutaminase-Regulated Transformed Growth Factor-β1 in the Parasite Links Schistosoma japonicum Infection with Liver Fibrosis. Mediators Inflamm 2015;2015:659378. [PMID: 26199461 DOI: 10.1155/2015/659378] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
5 Pereira TA, Syn WK, Machado MV, Vidigal PV, Resende V, Voieta I, Xie G, Otoni A, Souza MM, Santos ET. Schistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni. Clin Sci (Lond). 2015;129:875-883. [PMID: 26201095 DOI: 10.1042/cs20150117] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
6 Wen Y, Jeong S, Xia Q, Kong X. Role of Osteopontin in Liver Diseases. Int J Biol Sci 2016;12:1121-8. [PMID: 27570486 DOI: 10.7150/ijbs.16445] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
7 Chen BL, Peng J, Li QF, Yang M, Wang Y, Chen W. Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-β/Smad signaling. World J Gastroenterol 2013; 19(9): 1405-1415 [PMID: 23539268 DOI: 10.3748/wjg.v19.i9.1405] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]